Return to homepagePandemic Pact

Randomized clinical trial to evaluate the efficacy of different treatments in patients with COVID-19 requiring hospitalization

  • Funded by National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)
  • Total publications:0 publications

Grant number: COV20_00023

Grant search

Key facts

  • Disease

    COVID-19

  • Funder

    National Institute of Health Carlos III [El Instituto de Salud Carlos III] (ISCIII)

  • Principal Investigator

    José Ramón Arribas

  • Research Location

    Spain

  • Lead Research Institution

    FUNDACION PARA LA INVESTIGACIÇÿN BIOMEDICA DEL HOSPITAL UNIVERSITARIO LA PAZ

  • Research Priority Alignment

    N/A

  • Research Category

    Therapeutics research, development and implementation

  • Research Subcategory

    Prophylactic use of treatments

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Randomized Controlled Trial

  • Broad Policy Alignment

    Pending

  • Age Group

    Adults (18 and older)

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

There is an urgent need to evaluate the drugs currently in use and with potential efficacy for COVID-19 through clinical trials. This protocol evaluates the efficacy of various treatments in patients with severe SARS-CoV-2 pneumonia. The design of the study is an open, randomized CT that allows the addition / removal of treatment arms while the trial is ongoing in an adaptive way to the information that is generated in this study or in other available ones.